Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Total synthesis of (R,R,R)- and (S,S,S)-schweinfurthin F: differences of bioactivity in the enantiomeric seriesNolan R Mente, Andrew J Wiemer, Jeffrey D Neighbors, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 12, 2020
Prostate Cancer Incidence and Aggressiveness in Appalachia versus Non-Appalachia Populations in Pennsylvania by Urban-Rural Regions, 2004-2014Alicia C McDonald, Emily Wasserman, Eugene J Lengerich, et al.
Pharmacology|October 24, 2019
The Dopamine D2 Receptor Contributes to the Spheroid Formation Behavior of U87 Glioblastoma CellsJillian S Weissenrieder, Jessie L Reed, Michelle V Green, et al.
Bioorganic & Medicinal Chemistry|February 2, 2010
Structural analogues of schweinfurthin F: probing the steric, electronic, and hydrophobic properties of the D-ring substructureNatalie C Ulrich, John G Kodet, Nolan R Mente, et al.
Scientific Reports|January 11, 2022
RNAseq reveals extensive metabolic disruptions in the sensitive SF-295 cell line treated with schweinfurthinsJ S Weissenrieder, J D Weissenkampen, J L Reed, et al.
Pharmacology Research & Perspectives|May 18, 2021
Antipsychotic drugs elicit cytotoxicity in glioblastoma multiforme in a calcium-dependent, non-D2 receptor-dependent, mannerJillian S Weissenrieder, Jessie L Reed, George-Lucian Moldovan, et al.
Cancer|July 9, 2004
Phase II study of high-dose fish oil capsules for patients with cancer-related cachexiaC Patrick Burns, Susan Halabi, Gerald Clamon, et al.
Bioorganic & Medicinal Chemistry|March 1, 2008
Pivaloyloxymethyl-modified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylationAndrew J Wiemer, Jose S Yu, Larry W Shull, et al.
Leukemia & Lymphoma|April 18, 2009
Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myelomaAsher A Chanan-Khan, Ruben Niesvizky, Raymond J Hohl, et al.
Pageof 9